Intestinal Research (Jul 2019)

Subcutaneous integrin inhibitors may provide more treatment options for patients with moderate-to-severe ulcerative colitis

  • Hyuk Yoon

DOI
https://doi.org/10.5217/ir.2019.00070
Journal volume & issue
Vol. 17, no. 3
pp. 283 – 284

Abstract

Read online

No abstracts available.